Why Clovis Oncology Shares Got a Bump This Week

Why Clovis Oncology Shares Got a Bump This Week

Source: 
Motley Fool
snippet: 
  • Clovis may be benefitting from a short-squeeze effort by retail investors.
  • The jump was surprising considering the company’s disappointing second-quarter numbers.
  • The company has one marketed drug, Rubraca.